GFACX
Price
$71.12
Change
+$0.54 (+0.77%)
Updated
Jun 8 closing price
Net Assets
360.63B
SDGAX
Price
$127.24
Change
-$4.80 (-3.64%)
Updated
Jun 8 closing price
Net Assets
2.22B
Interact to see
Advertisement

GFACX vs SDGAX

Header iconGFACX vs SDGAX Comparison
Open Charts GFACX vs SDGAXBanner chart's image
GFACX vs SDGAX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. SDGAX commentary
Jun 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and SDGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 361B vs. SDGAX (2.22B). GFACX (0.00) and SDGAX (0.00) have matching dividends . GFACX was incepted earlier than SDGAX: GFACX (25 years) vs SDGAX (25 years). GFACX (1.35) is less costly to investors than SDGAX (0.89). GFACX is a more actively managed with annual turnover of: 32.00 vs. SDGAX (13.00). GFACX has a lower initial minimum investment than SDGAX: GFACX (250) vs SDGAX (1000). GFACX annual gain was more profitable for investors over the last year : 5.26 vs. SDGAX (2.57). SDGAX return over 5 years is better than : 9.63 vs. GFACX (8.05).
GFACXSDGAXGFACX / SDGAX
Total Expense Ratio1.350.89152%
Annual Report Gross Expense Ratio1.350.89152%
Fund Existence25 years25 years-
Gain YTD4.8742.128229%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets361B2.22B16,254%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.262.57205%
Returns for 3 years37.4030.53122%
Returns for 5 years8.059.6384%
Returns for 10 years80.7087.8692%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LODI25.190.03
+0.14%
AAM SLC Low Duration Income ETF
IBDV21.66N/A
N/A
iShares iBonds Dec 2030 Term Corp ETF
QQUP61.01N/A
N/A
ProShares Ultra Top QQQ
BBP84.10-0.61
-0.72%
Virtus LifeSci Biotech Products ETF
SOR45.08-0.37
-0.81%
Source Capital